Cas no 210581-39-8 (5-Fluoro-6-methyl-1H-indazole)
5-Fluoro-6-methyl-1H-indazole Chemical and Physical Properties
Names and Identifiers
-
- 5-Fluoro-6-methyl-1H-indazole
- 5-Floro-6-methyl (1H)indazole
- EN300-1592145
- 1H-Indazole,5-fluoro-6-methyl-(9CI)
- AKOS006290043
- 5-Fluoro-6-methyl-2h-indazole
- CS-0282107
- 210581-39-8
- DTXSID20646666
- SCHEMBL12121769
-
- MDL: MFCD09026992
- Inchi: 1S/C8H7FN2/c1-5-2-8-6(3-7(5)9)4-10-11-8/h2-4H,1H3,(H,10,11)
- InChI Key: MSHRIFJKLOZFKN-UHFFFAOYSA-N
- SMILES: FC1=CC2C=NNC=2C=C1C
Computed Properties
- Exact Mass: 150.05932639g/mol
- Monoisotopic Mass: 150.05932639g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 1
- Hydrogen Bond Acceptor Count: 2
- Heavy Atom Count: 11
- Rotatable Bond Count: 0
- Complexity: 151
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- XLogP3: 2
- Topological Polar Surface Area: 28.7?2
5-Fluoro-6-methyl-1H-indazole Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| Alichem | A269001151-1g |
5-Fluoro-6-methyl-1H-indazole |
210581-39-8 | 95% | 1g |
$657.20 | 2023-09-02 | |
| Chemenu | CM150381-1g |
5-fluoro-6-methyl-1H-indazole |
210581-39-8 | 95% | 1g |
$720 | 2021-08-05 | |
| Chemenu | CM150381-1g |
5-fluoro-6-methyl-1H-indazole |
210581-39-8 | 95% | 1g |
$*** | 2023-03-31 | |
| eNovation Chemicals LLC | Y0997420-5g |
5-Floro-6-methyl (1H)indazole |
210581-39-8 | 95% | 5g |
$1800 | 2024-08-02 | |
| Enamine | EN300-1592145-0.05g |
5-fluoro-6-methyl-1H-indazole |
210581-39-8 | 0.05g |
$1056.0 | 2023-06-04 | ||
| Enamine | EN300-1592145-0.1g |
5-fluoro-6-methyl-1H-indazole |
210581-39-8 | 0.1g |
$1106.0 | 2023-06-04 | ||
| Enamine | EN300-1592145-0.25g |
5-fluoro-6-methyl-1H-indazole |
210581-39-8 | 0.25g |
$1156.0 | 2023-06-04 | ||
| Enamine | EN300-1592145-0.5g |
5-fluoro-6-methyl-1H-indazole |
210581-39-8 | 0.5g |
$1207.0 | 2023-06-04 | ||
| Enamine | EN300-1592145-1.0g |
5-fluoro-6-methyl-1H-indazole |
210581-39-8 | 1g |
$1256.0 | 2023-06-04 | ||
| Enamine | EN300-1592145-2.5g |
5-fluoro-6-methyl-1H-indazole |
210581-39-8 | 2.5g |
$2464.0 | 2023-06-04 |
5-Fluoro-6-methyl-1H-indazole Related Literature
-
Chung-Sung Yang,Mong-Shian Shih,Fang-Yi Chang New J. Chem., 2006,30, 729-735
-
Eunkyung Choi,Minjoo Ryu,Haeri Lee,Ok-Sang Jung Dalton Trans., 2017,46, 4595-4601
-
Huading Zhang,Lee R. Moore,Maciej Zborowski,P. Stephen Williams,Shlomo Margel,Jeffrey J. Chalmers Analyst, 2005,130, 514-527
-
Peiyuan Zeng,Xiaoxiao Wang,Ming Ye,Qiuyang Ma,Jianwen Li,Wanwan Wang,Baoyou Geng,Zhen Fang RSC Adv., 2016,6, 23074-23084
Additional information on 5-Fluoro-6-methyl-1H-indazole
5-Fluoro-6-methyl-1H-indazole: A Comprehensive Overview
5-Fluoro-6-methyl-1H-indazole is a heterocyclic organic compound with the CAS number 210581-39-8. This compound belongs to the indazole family, which is a class of aromatic heterocycles containing two nitrogen atoms. The indazole ring system is known for its versatility and wide range of applications in pharmaceuticals, agrochemicals, and materials science. The 5-fluoro and 6-methyl substituents in this compound add unique electronic and steric properties, making it a valuable building block in organic synthesis.
The synthesis of 5-fluoro-6-methyl-1H-indazole involves a combination of nucleophilic aromatic substitution and cyclization reactions. Recent advancements in catalytic methods have enabled more efficient and selective pathways for its preparation. For instance, the use of transition metal catalysts such as palladium(0) complexes has significantly improved the yield and purity of this compound. These methods are particularly advantageous for large-scale production in the pharmaceutical industry.
One of the most notable applications of 5-fluoro-6-methyl-1H-indazole is in drug discovery. Its indazole core is a common structural motif in numerous bioactive molecules, including kinase inhibitors, anti-inflammatory agents, and antiviral drugs. The 5-fluoro group enhances the compound's ability to interact with biological targets through hydrogen bonding and π–π interactions, while the 6-methyl group provides steric bulk that can modulate binding affinity.
Recent studies have highlighted the potential of 5-fluoro-6-methyl-1H-indazole as a scaffold for developing novel anticancer agents. Researchers have demonstrated that derivatives of this compound exhibit potent inhibitory activity against various cancer cell lines, particularly those resistant to conventional chemotherapy. The mechanism of action involves disruption of key signaling pathways such as the PI3K/AKT/mTOR pathway, which is often dysregulated in cancer cells.
In addition to its therapeutic applications, 5-fluoro-6-methyl-1H-indazole has also found use in materials science. Its electron-deficient aromatic system makes it a promising candidate for organic electronics, such as field-effect transistors (FETs) and light-emitting diodes (LEDs). Recent experiments have shown that incorporating this compound into polymer blends can significantly enhance charge transport properties, paving the way for next-generation electronic devices.
The chemical stability of 5-fluoro-6-methyl-1H-indazole is another factor that contributes to its utility. It is relatively stable under ambient conditions, although it may undergo degradation under harsh acidic or basic conditions. Storage recommendations include keeping the compound in a cool, dry place away from light to maintain its integrity.
From a synthetic perspective, the regioselectivity of substituent placement on the indazole ring is critical for optimizing biological activity. The 5-fluoro and 6-methyl groups are strategically positioned to maximize their influence on the compound's electronic properties without compromising its aromaticity. This balance is essential for achieving desired pharmacokinetic profiles in drug candidates.
Looking ahead, ongoing research aims to further elucidate the structure–activity relationships (SAR) of 5-fluoro-6-methyl-1H-indazole derivatives. By systematically modifying substituent patterns, scientists hope to identify lead compounds with enhanced efficacy and reduced toxicity profiles. Such efforts are expected to accelerate the development of innovative therapeutics targeting complex diseases like cancer and neurodegenerative disorders.
In conclusion, 5-fluoro-6-methyl-1H-indazole stands out as a versatile and valuable molecule with diverse applications across multiple scientific disciplines. Its unique chemical properties, combined with recent advances in synthetic methodologies and biological applications, position it as a key player in contemporary research and development.
210581-39-8 (5-Fluoro-6-methyl-1H-indazole) Related Products
- 105391-69-3(5-Fluoro-4-methyl-1H-indazole)
- 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
- 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
- 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
- 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
- 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
- 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
- 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
- 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
- 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)